Human FcγRIIb (CD32b) NFAT Luciferase Reporter Jurkat Cell Line
Human FcγRIIb (CD32b) NFAT Luciferase Reporter Jurkat Cell Line is suitable for inhibitory Fc receptor signaling analysis, ADCC regulation studies, and therapeutic antibody optimization research.
Product Details
| Cat.No. | EDJ-RQ00015 | Product Name | Human FcγRIIb (CD32b) NFAT Luciferase Reporter Jurkat Cell Line |
|---|---|---|---|
| Species | Human | Cell Line | Jurkat |
| Cell Line Synonyms | JURKAT, JM, JM-Jurkat, Jurkat-FHCRC, Jurkat FHCRC, FHCRC-11, FHCRC subclone 11, FCCH1024 | Resistance Markers | Puromycin/ Hygromycin |
| Application Scenarios | ADCC negative regulation and antibody optimization | Morphology | Suspension |
| Passage Ratio | 1:2 | Complete Culture Medium | 1640+10% FBS |
| Freezing Medium | 95% complete culture medium+5% DMSO | Digestion Time | / |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
STR Profile
| Loci | STR Info (Sample Cell) Sample Cell Line: Jurkat | STR Info (Cell bank) Cell Line: Jurkat | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | Y | X | Y | ||||
| CSF1PO | 9 | 10 | 11 | 9 | 10 | 11 | ||
| CSF1PO | 10 | 11 | 10 | 11 | ||||
| CSF1PO | 10 | 12 | 10 | 12 | ||||
| CSF1PO | 11 | 11 | ||||||
| CSF1PO | 11 | 12 | 11 | 12 | ||||
| D2S1338 | 19 | 23 | 19 | 23 | ||||
| D2S1338 | 19 | 23 | 24 | 19 | 23 | 24 | ||
| D3S1358 | 15 | 15 | ||||||
| D3S1358 | 15 | 16 | 17 | 15 | 16 | 17 | ||
| D3S1358 | 15 | 17 | 15 | 17 | ||||
| D5S818 | 9 | 9 | ||||||
| D7S820 | 8 | 10 | 8 | 10 | ||||
| D7S820 | 8 | 10 | 11 | 8 | 10 | 11 | ||
| D7S820 | 8 | 12 | 8 | 12 | ||||
| D8S1179 | 12 | 14 | 15 | 12 | 14 | 15 | ||
| D8S1179 | 13 | 13 | ||||||
| D8S1179 | 13 | 14 | 13 | 14 | ||||
| D13S317 | 8 | 10 | 11 | 8 | 10 | 11 | ||
| D13S317 | 8 | 11 | 8 | 11 | ||||
| D13S317 | 8 | 11 | 12 | 8 | 11 | 12 | ||
| D13S317 | 8 | 12 | 8 | 12 | ||||
| D16S539 | 10 | 11 | 10 | 11 | ||||
| D16S539 | 11 | 11 | ||||||
| D18S51 | 13 | 14 | 20 | 21 | 13 | 14 | 20 | 21 |
| D18S51 | 13 | 21 | 13 | 21 | ||||
| D19S433 | 13 | 15.2 | 13 | 15.2 | ||||
| D19S433 | 13 | 16 | 13 | 16 | ||||
| D19S433 | 14 | 15.2 | 14 | 15.2 | ||||
| D21S11 | 31.2 | 32.2 | 31.2 | 32.2 | ||||
| D21S11 | 31.2 | 32.2 | 33.2 | 31.2 | 32.2 | 33.2 | ||
| D21S11 | 31.2 | 33.2 | 31.2 | 33.2 | ||||
| FGA | 20 | 21 | 20 | 21 | ||||
| FGA | 20 | 21 | 22 | 20 | 21 | 22 | ||
| FGA | 20 | 22 | 20 | 22 | ||||
| Penta D | 11 | 13 | 11 | 13 | ||||
| Penta E | 9 | 10 | 12 | 9 | 10 | 12 | ||
| Penta E | 10 | 12 | 10 | 12 | ||||
| TH01 | 6 | 9.3 | 6 | 9.3 | ||||
| TPOX | 8 | 9 | 10 | 8 | 9 | 10 | ||
| TPOX | 8 | 10 | 8 | 10 | ||||
| vWA | 16 | 17 | 18 | 16 | 17 | 18 | ||
| vWA | 16 | 17 | 19 | 20 | 16 | 17 | 19 | 20 |
| vWA | 17 | 18 | 19 | 17 | 18 | 19 | ||
| vWA | 17 | 18 | 19 | 20 | 17 | 18 | 19 | 20 |
| vWA | 18 | 18 | ||||||
| vWA | 18 | 19 | 20 | 18 | 19 | 20 | ||
| vWA | 18 | 20 | 18 | 20 | ||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.